RxDoctor Payments Data

Paul Day, MD

Family Medicine · Cincinnati, OHNPI 1346655966

Payments from drug & device makers

$1,174in general payments, 2019–2025

Across 86 payments — averaging $13.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$429
  • Novo Nordisk$172
  • Dexcom, Inc.$102
  • Johnson & Johnson$81
  • Amgen$71
  • Exact Sciences$45
  • plus $276 from 11 others

What the payments were for

  • Food & beverage$1,174100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,174 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$34,150
Medicare patients
96
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide86$97,568
JanuviaSitagliptin Phosphate55$74,839
JardianceEmpagliflozin53$68,219
EliquisApixaban40$46,234
RexultiBrexpiprazole17$43,868
OzempicSemaglutide41$40,272
FarxigaDapagliflozin Propanediol24$34,946
UbrelvyUbrogepant16$31,208
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr36$17,294
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$13,782
XareltoRivaroxaban22$12,947
Combivent RespimatIpratropium/Albuterol Sulfate19$10,805
Breo ElliptaFluticasone/Vilanterol11$4,522
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,195
Atorvastatin Calcium311$2,791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$25$97,56886 claims
PfizerEliquis$28$46,23440 claims
Novo NordiskOzempic$172$40,27241 claims
GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta$28$35,59870 claims
AstraZenecaFarxiga$36$34,94624 claims
AbbVieUbrelvy$429$31,20816 claims
Johnson & JohnsonXarelto$81$12,94722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →